GLOBAL PHARMA INSIGHT The Definitive Guide to Drug Discovery and Pharmaceutical Manufacturing Edited by Deanna Wilson Published by Sovereign Publications

Producing new medicines is an increasingly complex business. An industry founded on studying chemical processes is now incorporating biopharmaceuticals, or the study of the cell, into its range of development and manufacturing approaches. An exciting new era lies ahead.

GLOBAL PHARMA INSIGHT aims to chart this progression, looking at the trends that appear as the industry searches for innovative new drugs that positively extend the existing treatment tools available to the physician, or that tackle the many diseases that have no treatment at present.

In this competitive industry, time to market matters, and GLOBAL PHARMA INSIGHT will explore the strategies, technologies and services that can streamline development time while cutting overall costs. In these days of high-throughput screening, what can be done to eliminate development bottlenecks? Can outsourcing to contract research organisations help? What is the role of IT? Are consultancies a hindrance or a help?

The ins and outs of patent issues will also be explored. What strategies can be used to extend patent life in the face of upcoming generic versions? What inroads is the generics market making?

This industry is one that is regrouping, reforming – and lining up for a future that will be every bit as productive as its past. And throughout, GLOBAL PHARMA INSIGHT will be putting the emphasis on quality issues, just as the industry does.

'The $350bn pharmaceutical manufacturing industry is growing at 10 per cent a year and enjoys margins of over 35 per cent.'
The Economist

'With the current operating environment, there has never been a greater need for information on the activities of the global pharmaceutical industry.'
Centre for Medicine Research

Deanna Wilson is an award winning London-based freelance journalist and editor, with extensive experience of editing and writing in the medical, healthcare and pharmaceuticals fields. She has been launch editor of a number of publications, including Pharmaceutical Visions, a quarterly magazine for the global industry, the European Journal of Parenteral Sciences, a quarterly peer-reviewed journal for the UK Parenteral Society, and Pharmaceutical Marketing, a UK-based monthly magazine for marketeers in the industry.

The following organizations have agreed to support GLOBAL PHARMA INSIGHT. Copies of the publication will be sent to all their members.

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the research-based pharmaceutical industry operating in Europe.

Through its direct membership of 28 national pharmaceutical industry associations and 44 leading pharmaceutical companies, EFPIA is the voice on the European scene of about 2,000 companies committed to researching, developing and bringing to patients new medicines that improve health and the quality of life around the world.

For more information, please visit http://www.efpia.org/

---

Association of the British Pharmaceutical Industry (ABPI)

The Association of the British Pharmaceutical Industry (ABPI) is the trade association for more than 75 companies in the UK producing prescription medicines. Its member companies research, develop, manufacture and supply more than 80 per cent of the medicines prescribed through the National Health Service. The industry employs some 73,000 people directly and generates another 250,000 jobs in related industries. Its 2005 trade surplus was £3.4 billion - the highest in the UK.

For more information, please visit http://www.abpi.org.uk/

Companies that have been invited to contribute editorial for the new edition of GLOBAL PHARMA INSIGHT include:

Pfizer GlaxoSmithKline Merck AstraZeneca Boehringer Ingelheim Johnson & Johnson Novartis Bristol-Myers Squibb Pharmacia Wyeth

Abbott Labs Schering-Plough Sanofi-Aventis Sanofi-Synthelabo Takeda Schering AG Bayer Daiichi Sankyo Akzo Nobel Eisai

The key to the success of GLOBAL PHARMA INSIGHT is the quality of the readership, which is projected at 60,000 senior technical, scientific and executive personnel at all leading pharmaceutical and biotechnology companies worldwide as well as CROs and CMOs (Publisher’s Survey).

Copies of GLOBAL PHARMA INSIGHT are distributed in both print and electronic format.

The readership by job title includes:

This entails a guaranteed minimum of 10,200 copies, which will generate a projected readership of 60,000 (publisher's statement) decision-makers in the buying chain at all leading pharmaceutical and biotechnology companies worldwide as well as CROs and CMOs:

“C Level" CEO President CFO COO CIO Senior Board Members Manufacturing VP Manufacturing Technical Director Production Director Operations Manager Senior Production Planners Head of Production Quality Control & Assurance Manager General Manager of Processing

Business Management Business Unit Manager IT Director Managing Director Heads of Licensing Heads of Regulatory Affairs Purchasing Directors R & D Chief Scientific Officer R&D Manager Senior VP Research, Development and Engineering R&D Director Head Clinical Research Drug Discovery VP Research Chemist/Managers Laboratory Directors

A minimum of 10,000 copies are distributed and additional copies are made available for sale.

GLOBAL PHARMA INSIGHT is designed to provide advertisers with qualified responses from new customers through the following mechanisms:

READER REPLY CARD SERVICE

Each copy of GLOBAL PHARMA INSIGHT contains a reply card, which readers can fill out to receive more information on advertisers. As part of our service, for a period of 12 months following publication we will:

• Transmit all reader responses to you by fax or email within 24 hours of receiving them, so that you can contact your new potential customers without delay.
• Monitor all responses to ensure you receive only genuine qualified enquiries.
• Send you a summary report of all the responses you have received every quarter so that you can assess the quantity and quality of new business your advertisement has generated.

SEARCH ENGINE MARKETING

The Internet has become the most important tool for finding information quickly. It is therefore essential that your company achieves high search engine rankings because only the first few results returned by a search engine are ever actually visited. To enable your company to achieve the best possible rankings on GOOGLE – the world's number one search engine – we will work with you to create a 600 word Profile, optimised for the search engines, which will appear on the official GLOBAL PHARMA INSIGHT website.

All search engine studies have shown that the single most important and reliable method to improve the ranking of your own website is to have links into your site from relevant, highly - ranked sites, such as the GLOBAL PHARMA INSIGHT website. Search engine algorithms identify these links, assessing their importance and will reflect this in the subsequent ranking of your website.

To further ensure that you get the maximum amount of targeted traffic to your company's own website we will:

• Identify the best combination of keywords for your business and create the relevant <title> and other meta tags based on our research.
• Edit the text of your Profile to ensure the correct balance of keywords for optimal search engine visibility.
• As a high-ranking site, GOOGLE regularly visits the GLOBAL PHARMA INSIGHT website, thus maintaining your highly-ranked presence on its search engine.

Aside from driving more targeted traffic to your website, achieving high search engine rankings provides an extremely powerful and cost-effective method of building brand awareness.

85% of all Internet searches are conducted through GOOGLE.

DIRECT CLIENT CONTACT

Your advertisement will be strategically placed in a pre-agreed position next to relevant editorial within the publication. As a result, readers will be able to get in touch with you directly using the contact information contained in your advertisement. The precisely targeted circulation ensures that you will receive qualified enquiries from genuine buyers.

• The reader response service in operation for 12 months after publication
• A Search Engine Optimised Company Profile on the official GLOBAL PHARMA INSIGHT website
• A strategically placed advertisement in GLOBAL PHARMA INSIGHT
• A fully guaranteed precisely targeted circulation
• A complimentary copy of GLOBAL PHARMA INSIGHT upon publication

 

Advertising Rates 4 Colour 2 Colour Black & White Double Page £13,950 £13,500 £12,950 Single Page £7,950 £7,500 £6.950 Half Page £4,950 £4,500 £3,950   Special Positions   Inside Front Cover – Double Page Spread £19,500 Outside Back Cover £17,500 Inside Back Cover – Single Page £11,500 Opposite Foreword £11,500 Opposite Contents Page £10,500 Book Mark – 20 gms per insert £14,495 Loose Leaf Inserts - 20 gms per insert £9,900   Sponsorship   Exclusive Section Sponsors 1st Double Page Spread position in the section Sponsor Logo on Outside Front Cover Sponsor logo on relevant section of publication website with hyperlink back to your own website 500 copies of the book supplied to your HQ upon publication 100 copies of the publication to be mailed to your key customers upon publication 1000 reprints of your editorial and advertisement £25,000		Special Features   8 Page Full Colour £44,850 6 Page Full Colour £34,850 4 Page Full Colour £24,850
		Publication Format A4 Publication Date Winter 2007 Agency Discount 10%

Click here to obtain a copy of GLOBAL PHARMA INSIGHT